Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,580 public trials 828 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Recruiting

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

NCT07075185

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +24 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Palo Alto, California, United States
  • UCSF San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Recruiting

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

NCT06379789

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California Davis Sacramento, California, United States
View all 44 locations
View Trial Details
Recruiting

Mosaic Trial for Stem Cell Transplant Recipients

NCT06960993

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Transplant, +22 more
Locations
  • Georgetown University School of Medicine Washington D.C., District of Columbia, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Hackensack Meridian Health Nutley, New Jersey, United States
View Trial Details
Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

NCT05137054

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Scripps Clinic Torrey Pines La Jolla, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Indiana University Health Simon Cancer Center Indianapolis, Indiana, United States
  • Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
View all 42 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

NCT06953960

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Southern California /ID# 272414 Los Angeles, California, United States
  • Yale University School of Medicine /ID# 272447 New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute /ID# 271846 Boston, Massachusetts, United States
  • University of Michigan Health System - Ann Arbor /ID# 271536 Ann Arbor, Michigan, United States
View all 48 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

NCT07416604

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Center for Inherited Blood Disorders Orange, California, United States
  • Innovative Hematology, Inc. Indianapolis, Indiana, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • Washington Center for Bleeding Disorders Seattle, Washington, United States
View Trial Details

Related conditions